In Science this week, researchers at Harvard Medical School and elsewhere report their use of "large-scale quantitative phosphoproteomics experiments to define the signaling networks downstream of mTORC1 and mTORC2.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.